Prosight Management as of Dec. 31, 2020
Portfolio Holdings for Prosight Management
Prosight Management holds 42 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alexion Pharmaceuticals | 12.7 | $28M | 176k | 156.24 | |
| Organogenesis Hldgs (ORGO) | 7.0 | $15M | 2.0M | 7.53 | |
| Prothena Corp SHS (PRTA) | 6.1 | $13M | 1.1M | 12.01 | |
| Cue Biopharma (CUE) | 5.2 | $11M | 907k | 12.51 | |
| Arena Pharmaceuticals Com New | 5.2 | $11M | 146k | 76.83 | |
| Bristol Myers Squibb (BMY) | 4.8 | $11M | 169k | 62.03 | |
| Baxter International (BAX) | 4.5 | $9.7M | 121k | 80.24 | |
| Encompass Health Corp (EHC) | 4.4 | $9.5M | 114k | 82.69 | |
| Cigna Corp (CI) | 4.0 | $8.6M | 41k | 208.17 | |
| Change Healthcare | 3.6 | $7.8M | 421k | 18.65 | |
| Aurinia Pharmaceuticals (AUPH) | 3.3 | $7.0M | 509k | 13.83 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.2 | $6.8M | 29k | 236.33 | |
| Albireo Pharma | 3.0 | $6.6M | 175k | 37.51 | |
| Alexion Pharmaceuticals Call Call Option | 2.9 | $6.3M | 40k | 156.25 | |
| Aldeyra Therapeutics (ALDX) | 2.9 | $6.2M | 909k | 6.86 | |
| Meiragtx Holdings (MGTX) | 2.7 | $5.8M | 381k | 15.14 | |
| Zimmer Holdings (ZBH) | 2.5 | $5.5M | 36k | 154.08 | |
| Cara Therapeutics | 2.1 | $4.4M | 294k | 15.13 | |
| Metacrine Ord | 2.0 | $4.4M | 563k | 7.86 | |
| Inovalon Hldgs Com Cl A | 1.9 | $4.2M | 231k | 18.17 | |
| Aptose Biosciences Com New | 1.7 | $3.6M | 825k | 4.38 | |
| Twist Bioscience Corp Put Put Option | 1.6 | $3.5M | 25k | 141.28 | |
| Magellan Health Com New | 1.5 | $3.1M | 38k | 82.83 | |
| Zogenix Com New | 1.4 | $3.0M | 150k | 19.99 | |
| Centene Corporation (CNC) | 1.1 | $2.4M | 40k | 60.02 | |
| Prothena Corp Call Call Option | 1.0 | $2.1M | 175k | 12.01 | |
| Uniqure Nv SHS (QURE) | 0.9 | $1.9M | 54k | 36.12 | |
| Adma Biologics (ADMA) | 0.8 | $1.7M | 883k | 1.95 | |
| Veracyte Put Put Option | 0.8 | $1.7M | 35k | 48.94 | |
| Reata Pharmaceuticals Cl A | 0.7 | $1.5M | 12k | 123.60 | |
| Spdr Ser Tr Put Put Option | 0.7 | $1.4M | 10k | 140.80 | |
| Arena Pharmaceuticals Call Call Option | 0.6 | $1.4M | 18k | 76.83 | |
| Immatics SHS (IMTX) | 0.5 | $1.1M | 105k | 10.79 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.5 | $1.1M | 255k | 4.20 | |
| Mirum Pharmaceuticals (MIRM) | 0.5 | $1.1M | 60k | 17.46 | |
| Magenta Therapeutics | 0.5 | $985k | 126k | 7.84 | |
| Ark Etf Tr Put Put Option | 0.4 | $933k | 10k | 93.30 | |
| Beam Therapeutics Put Put Option | 0.4 | $816k | 10k | 81.60 | |
| Akumin | 0.3 | $675k | 224k | 3.01 | |
| LHC | 0.3 | $586k | 2.7k | 213.40 | |
| Ac Immune Sa SHS (ACIU) | 0.0 | $46k | 8.9k | 5.14 | |
| Moderna (MRNA) | 0.0 | $18k | 174.00 | 103.45 |
